Brexit ‘worry’ for big Irish drug firms

Uncertainty over the future of Britain remaining in the EU has big pharmaceutical manufacturers in Ireland, and around the world, worried.

The market is an important one for pharmaceutical companies located in Ireland. Last year the UK bought €36.4bn worth of pharmaceuticals, €3.5bn of this coming from Ireland.

Of most concern for pharmaceutical manufacturers is disruption to the supply chain to hospitals, pharmacies and sub-supply between their manufacturing plants across the Irish Sea and the English Channel which will inevitably arise if the UK exits.